BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

American Med Tech, Inc. Merger or Acquisition?


2/25/2009 8:33:59 AM

CHARLES TOWN, W. Va., Feb. 24 /PRNewswire-FirstCall/ -- American Med Tech, Inc. today announced that their CEO, Executive VP and International Marketing Manager have returned from a mysterious "fact finding" visit to an as yet unnamed suitor.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)

"We discussed first and foremost adapting certain of our diabetic personal hygiene product line that utilizes proprietary silver to enable them to put these products on the shelves of thousands of retail pharmacies all across the USA," said David Phillips, Ph.D. CEO.

Additionally, Dr. Phillips reports: "We also discussed several other things that I am not at liberty to reveal right now."

Finally, Dr. Phillips told reporters today: "It would have to be important for this many key managers to travel together."

Inquiries can be made at www.americanmedtech.com. E mail inquiries can be sent to davidphillipsmail@yahoo.com. Phone is 304-725-2202.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.



CONTACT: David Phillips of American Med Tech, Inc., +1-304-725-2202,
davidphillipsmail@yahoo.com

Web site: http://www.americanmedtech.com/


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->